English appeals court refuses Neurim injunction for insomnia drug
26-06-2020
Teva to face inhaler infringement allegations in UK court
03-06-2020
Partial win for Mylan as Fed Circuit cancels Boehringer patents
17-03-2020
ricochet64 / Shutterstock.com
In a victory for Mylan, the English High Court has rejected Israel-based pharmaceutical company Neurim’s attempt to delay a generic version of its insomnia medication.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
English High Court, Mylan, Neurim, generic, injunction, insomnia, patent infringement, Circadin
